Alpha-1 antitrypsin deficiency and the risk of hepatocellular carcinoma in end-stage liver disease

doi:10.4254/wjh.v7.i10.1427

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6989)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

408

WORD

287

HTML

3335

Figures (1-2)

140

Tables (1-1)

142

Sum=4312

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

954

Download

1723

Sum=2677

Jun 8, 2015 (publication date) through Jul 22, 2024

Times Cited of This Article

Times Cited (35)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Hepatol. Jun 8, 2015; 7(10): 1427-1432
Published online Jun 8, 2015. doi: 10.4254/wjh.v7.i10.1427

Full Size Figure Download Figure

Figure 1 Cumulative incidence of hepatocellular carcinoma. HCC: Hepatocellular carcinoma; A1ATD: Alpha-1 antitrypsin deficiency.

Citation: Antoury C, Lopez R, Zein N, Stoller JK, Alkhouri N. Alpha-1 antitrypsin deficiency and the risk of hepatocellular carcinoma in end-stage liver disease. World J Hepatol 2015; 7(10): 1427-1432
URL: https://www.wjgnet.com/1948-5182/full/v7/i10/1427.htm
DOI: https://dx.doi.org/10.4254/wjh.v7.i10.1427